Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by stockmonster6on Apr 14, 2021 4:57pm
234 Views
Post# 32994918

nothing has changed - except more progress

nothing has changed - except more progressThose not wanting to wait, are and have sold off. They want millions and retirement now, and aren't willing to wait for THRM to produce their test.

THRM continually has met their benchmarks and demonstrated their test works against live subject to the same levels as in tests. 100%/ 100%.  

Now, they are going to determine if the test can be successful against variants - very important.

News regarding Health Canada is still pending, and should be out soon.

Nothing has changed except we are further along in the process and investors can be confident the test works!

But, it is also a good time to pick up some more cheaper shares. This is only temporary.  We went from $1.05 to .33 for no specific reason, and people are 'bored' for some reason.

Can't wait for May or June.  Well it  takes time.  I have a few months to wait.  I'm not worried.
<< Previous
Bullboard Posts
Next >>